Augmenting glial cell-line derived neurotrophic factor signaling to treat painful neuropathies.
Departments of Neurology and Neuroscience, The Johns Hopkins School of Medicine, Baltimore, MD 21205.
Ahmet
A
Höke
D000818:Animals; D004916:Erythromelalgia / Q000188:drug therapy*; D051097:Glial Cell Line-Derived Neurotrophic Factor Receptors / Q000378:metabolism*; D051096:Proto-Oncogene Proteins c-ret / Q000378:metabolism*; D011804:Quinolines / Q000627:therapeutic use*; D015398:Signal Transduction
C494987:GFRA1 protein, human; D051097:Glial Cell Line-Derived Neurotrophic Factor Receptors; D011804:Quinolines; C470912:XIB 4035; D051096:Proto-Oncogene Proteins c-ret